High international profile
In 10 years, starting from scratch, the ICAN IHU has gradually increased its attractiveness and its national and international visibility to become an internationally renowned institute in the field of cardiometabolic pathologies.
ICAN researchers and clinicians are involved in 19 large-scale projects, 8 of which are European.
These projects include
- 2 projects coordinated by ICAN researchers (METACARDIS and MAESTRIA),
- 1 European ERN-type project,
- 4 European public-private collaborative projects under the Innovative Medicine Initiative (IMI),
- 2 Fondation Leducqtransatlantic networks of excellence , an F-CRIN clinical investigation network,
- 2 public-private partnership projects in university hospital research
- 2 structuring competitiveness cluster projects (PSPC).
The IHU ICAN teams received a European Research Council “consolidator grant ” and attracted more than 55 foreign researchers.
2 international laboratories have been set up, one with Mount Sinai Hospital in New York and the other with John Hopkins Hospital in Baltimore.
The ICAN IHU has organised 6 international symposia (ICAN-series – 400 participants) on cardiometabolic diseases and participates in an international exchange programme with the CMDO (Canadian Cardiometabolic, Diabetes and Obesity Research Network).
